Figure 2. Effect of addition of clavulanic acid (10 μL of 1,000 μg/mL) to the zones of inhibition of the three carbapenem disks. Top row (left to right): imipenem, meropenem, and ertapenem disks without clavulanic acid. Bottom row (left to right): imipenem, meropenem, and ertapenem disks with clavulanic acid.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.